For research teamsHelp me find a study
Back to all studies
CompletedNCT02604407

Safety study of SHP465 in ADHD

This study is completed in the United States. It is testing SHP465 for ADHD.

ADHDDrugFrom 18 Years to 55 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether SHP465 may be useful for adults experiencing ADHD.

What would participation involve?

Participants may receive SHP465, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with ADHD.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: November 19, 2015
Recruitment status
Completed
Enrollment listed in the registry
275
Sponsor
Shire
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT02604407
Official title
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02604407. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 45 sites
  • Pharmacology Research Institute
    Encino, California
    Site status: Not listed — confirm with the team
  • Pharmacology Research Institute (Pri)
    Los Alamitos, California
    Site status: Not listed — confirm with the team
  • Pharmacology Research Institute (Pri)
    Newport Beach, California
    Site status: Not listed — confirm with the team
  • Nrc Research Institute
    Orange, California
    Site status: Not listed — confirm with the team
  • Elite Clinical Trials
    Wildomar, California
    Site status: Not listed — confirm with the team
  • McB Clinical Research
    Colorado Springs, Colorado
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center Llc
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Gulfcoast Clinical Research Center
    Fort Myers, Florida
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions, Inc
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center, Llc
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • Qps Mra, Llc
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Medical Research Group of Central Florida
    Orange City, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions, Inc
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Northwest Behavioral Research Center
    Marietta, Georgia
    Site status: Not listed — confirm with the team
  • Capstone Clinical
    Libertyville, Illinois
    Site status: Not listed — confirm with the team
  • Baber Research Group, Inc
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Psychiatric Associates
    Overland Park, Kansas
    Site status: Not listed — confirm with the team
  • Louisiana Research Associates, Inc.
    New Orleans, Louisiana
    Site status: Not listed — confirm with the team
  • Rochester Center For Behavioral Medicine
    Rochester Hills, Michigan
    Site status: Not listed — confirm with the team
  • Clinical Neurophysiology Services
    Sterling Heights, Michigan
    Site status: Not listed — confirm with the team
  • Psychiatric Care and Research Center
    O'Fallon, Missouri
    Site status: Not listed — confirm with the team
  • Midwest Research Group
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Premier Psychiatric Research Institutute
    Lincoln, Nebraska
    Site status: Not listed — confirm with the team
  • Center For Psychiatry and Behavioral Medicine, Inc
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Princeton Medical Institute
    Princeton, New Jersey
    Site status: Not listed — confirm with the team
  • Bioscience Research Llc
    Mount Kisco, New York
    Site status: Not listed — confirm with the team
  • Nyu Langone Medical Center
    New York, New York
    Site status: Not listed — confirm with the team
  • Richard H Weisler, Md, Pa & Associates
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • Midwest Clinical Research Center
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Ips Research Company
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Oregon Center For Clinical Investigations, Inc
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Oregon Center For Clinical Investigations
    Salem, Oregon
    Site status: Not listed — confirm with the team
  • Omega Medical Research
    Warwick, Rhode Island
    Site status: Not listed — confirm with the team
  • Rainbow Research, Inc.
    Barnwell, South Carolina
    Site status: Not listed — confirm with the team
  • Coastal Carolina Research
    Mt. Pleasant, South Carolina
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Futuresearch Trials of Dallas, Lp
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Bayou City Research, Ltd
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Red Oak Psychiatry Associates
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Houston Clinical Trials, Llc
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Research Across America
    Plano, Texas
    Site status: Not listed — confirm with the team
  • Neuroscience, Inc
    Herndon, Virginia
    Site status: Not listed — confirm with the team
  • Eastside Therapeutic Resource
    Kirkland, Washington
    Site status: Not listed — confirm with the team
  • Summit Research Network (Seattle) Llc
    Seattle, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving SHP465 12.5mg capsules (one capsule daily), Placebo, SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily). Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with adhd; age range: From 18 Years to 55 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Shire, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.